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THE ECONOMICS OF PREVENTION AND
MEDICARE: THE CHALLENGE, POTENTIAL
SOLUTIONS AND CURRENT RESULTS
Adam Atherly, Ph.D.,* Zhou Yang**
INTRODUCTION
The purpose of this paper is to explore the potential role of
"prevention" in helping to control future Medicare costs.
Medicare is the biggest public financed health insurance
program in the United States.' Medicare provides subsidized
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1. See THE BDS. OF TR., THE 2009 ANNUAL REPORT OF THE FEDERAL HOSPITAL
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health insurance coverage for forty-five million beneficiaries -
thirty-seven million over age sixty-five - and pays for the
majority of beneficiaries' inpatient care, outpatient physician
care, and a large proportion of their outpatient prescription
drugs. 2 In 2008, the total budget of Medicare was $468 billion.3
Medicare, however, is widely believed to be underfunded
and unlikely to be able to meet its future financial obligations.4
The Medicare Trustees project that the Part A trust fund will be
exhausted in 2017 under their "intermediate" assumptions about
health care and wage growth rates.5  By 2014, Medicare
spending will outstrip its statutory financing by approximately
forty-five percent. 6 For the past four reports, the Medicare
Trustees have issued a statutorily required "Medicare funding
warning," because general revenues have exceeded
predetermined thresholds for total Medicare financing.7 Over
the next seventy-five years, the actuarial deficit in the program is
equal to 3.88% of the total taxable payroll for Part A alone.' This
impending bankruptcy has spurred policymakers to begin to
address potential solutions to keep the trust fund solvent.
SUMMARY OF THE CHALLENGES
Medicare fundamentally faces three challenges over the next
decade: 1) an increase in the number of beneficiaries, both in
absolute numbers and relative to the number of workers paying
into the fund; 2) a continuing differential between the growth
rate in health care spending and wages; and 3) an increase in the
"risk profile" of new beneficiaries. Combined, these three
factors are expected to continue to lead to increases in spending
INSURANCE AND FEDERAL SUPPLEMENTARY MEDICAL INSURANCE TRUST FUNDS 31
(2009), available at https://www.cms.gov/ReportsTrustFunds/downloads/tr2009.pdf.
2. See id. at 1-2.
3. Id. at 2.
4. Id. at 2, 60.
5. Id. at 2.
6. Id. at 3.
7. Id.
8. Id.
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which outstrip increases in contributions to the trust fund.9
This paper discusses each of the three challenges in turn
and then looks at the potential role of prevention. The basic
question we ask is whether, given the current Medicare
framework, prevention reasonably can be expected to play a
major role in controlling Medicare spending and bringing the
trust fund back into balance.
CHALLENGE 1: THE INCREASING NUMBER OF BENEFICIARIES
The first major challenge is the expected increase in the size
of the elderly population. This is caused by both an increase in
the number of eligible beneficiaries, as the first cohort of baby
boomers turn sixty-five in 2010,10 and because of increasing
longevity among beneficiaries." The implications of the baby
boom generation's retirement for Medicare spending have been
widely discussed in both the professional community and the
popular press. 2 When the "baby boomers" (born between 1943
and 1960) begin to turn sixty-five in 2010, Medicare will be
subject to substantial short and long-term cost growth
challenges, centered on the expected dramatic increase in the
total number of beneficiaries.13
Further, increasing life expectancy will also lead to higher
Medicare costs. 4  Unlike private insurance coverage among
working adults, which is subject to constant adjustments in
coverage, copayments, and deductibles, Medicare is an
entitlement program that covers beneficiaries from age sixty-five
to death.'5 Therefore, Medicare costs per year, per beneficiary
9. Id. at 4, 11,33.
10. Id. at 11.
11. Id.
12. Id. at 36.
13. Id. at 18.
14. Id. at 11.
15. Medicare covers both age eligible individuals (over age sixty-five) plus
several other categorical groups, such as those with end stage renal disease. Id. at
135. We focus in this paper on the age-eligible beneficiaries. However, obesity
likely also changes spending for other groups such as the disabled.
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are not the only concern; instead, changes in lifetime costs from
age sixty-five to death per beneficiary will determine the effect
on Medicare's long-term financial viability.16
Combined, these two effects are predicted to increase the
number of Medicare beneficiaries from today's enrollment of
approximately forty-five million to eighty million by 2030.'1
CHALLENGE 2: THE DIFFERENTIAL BETWEEN THE GROWTH RATE IN
HEALTH CARE SPENDING AND WAGES
The second major challenge is the long-term differential
between the growth rate in Medicare spending and in wages.
This challenge is seen most clearly by focusing on Part A.
Medicare Part A is financed by a 2.9% payroll tax."s In 2008, this
tax generated $199 billion in revenues.19 The program spent
$232 billion on benefits for eligible beneficiaries, a deficit of
approximately $33 billion, which was covered in a variety of
ways .2
If the number of workers per beneficiary was held constant,
and if wages grew at the same rate as Part A spending, then the
deficit would be constant.21 If wages grow more quickly than
spending, the deficit would decline. 2 2  However, historically,
Part A has grown an average of two to three percentage points
more quickly than the overall economy. 23 This difference creates
a structure where the increase in spending is always greater than
the increase in revenues, which will eventually create a spending
deficit regardless of the tax level. Indeed, in the Medicare
Trustees' long-term projections, they assume a convergence of
16. Id. at 11.
17. Id. at 37.
18. Id. at 5.
19. Id.
20. Id. at 52.
21. See id. at 6.
22. This is one of the ideas behind "fixing" Social Security - recalculate the
automatic increase in benefits so that it is less than the growth in wages. Some
models suggest this technical fix alone would bring Social Security into balance.
23. Id. at 41.
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the growth rate of health care spending and GDP growth,
although there is no historical precedence for such an
occurrence.2 4
Parts B and D are drawn from the general federal revenue
fund, so the situation is a bit more complex. 2 5 The key difference
is that Parts B and D can also be sustained by reductions in other
programs financed by the federal government, such as defense
or transportation. Over the past five years, Part B costs have
increased by an average of approximately 8%.26 The Trustees
project an annual Part B growth rate of between 8.5 and 9% over
the next ten years. 27 For Part D, spending is projected to increase
by 11% per year.28
In contrast, the Trustees project the economy to grow at
4.6% per year.29 Note that this rate of growth has not been
achieved in a single year over the past seven years.30 Since 2003,
the economy has grown at a real average of 2.3%.31 However, a
growth rate of 4.6% is insufficient to maintain the program as
currently structured. By the end of the Trustees' projection
window, Parts A, B and D combine to consume 11.3% of GDP,
up from the current 3.3% of GDP.32
CHALLENGE 3: A CHANGING RISK PROFILE
Medicare beneficiaries in the future will be considerably
different from the beneficiaries of today.33 Future Medicare
beneficiaries will have fewer children (and more women with
24. Id. at 41, 178.
25. Id. at 21.
26. Id.
27. Id.
28. Id. at 25-26.
29. Id. at 28.
30. Id. at 41.
31. Id.
32. Id. at 3.
33. MEDICARE PAYMENT ADVISORY COMM'N, REPORT TO THE CONGRESS:
PROMOTING GREATER EFFICIENCY IN MEDICARE xi (2007), available at
http://www.medpac.gov/documents/jun07_EntireReport.pdf.
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children after age thirty-five) with children living farther away.34
The racial compensation of Medicare beneficiaries will change,
with more beneficiaries being Hispanics and other minority
groups.35 There will be initially fewer beneficiaries age eighty-
five or older, then, as the baby boom generation ages, more
beneficiaries over age eighty-five.36 New beneficiaries will be, as
a group, more educated but with more income variation.37
There will also be fewer beneficiaries with disabilities. 38 Most Of
these changes will lead to increased health care costs.3 9
But the biggest expected change is an increase in the rate of
obesity in the Medicare population. 40 The United States is
experiencing an ever-increasing prevalence of obesity as
measured by BMI. 4 1 Future Medicare beneficiaries are likely to
have higher prevalence of chronic diseases as the epidemic of
obesity enters the older population.42 Existing research indicates
that obesity-induced chronic diseases such as diabetes,
hypertension, and heart failure will increase the demand for
health care and Medicare expenditures.43
Examining lifetime costs presents three major challenges to
the estimation of the Medicare expenditures attributed to
demographic and biological changes in the Medicare
population. First, considering the epidemic of obesity, the
34. Id. at 4.
35. Id.
36. Id.
37. Id. at 5.
38. Michael E. Chernew et al., Disability and Health Care Spending Among
Medicare Beneficiaries, 24 HEALTH AFF. W5-R42, W5-R43 (Supp. 2005).
39. MEDICARE PAYMENT ADVISORY COMM'N, supra note 33, at 3-4.
40. Id. at 8.
41. Richard P. Troiano & Katherine M. Flegal, Overweight Children and
Adolescents: Description, Epidemiology, and Demographics, 101 PEDIATRICS 497, 500
(1998); Katherine M. Flegal et al., Prevalence and Trends in Obesity Among U.S. Adults,
288 JAMA 1723, 1723 (2002).
42. MEDICARE PAYMENT ADVISORY COMM'N, supra note 33, at 9-10.
43. Kenneth E. Thorpe et al., Which Medical Conditions Account for the Rise in
Health Care Spending? 23 HEALTH AFF. W4-437, W4-440 (Supp. 2004); Kenneth E.
Thorpe, The Rise in Health Care Spending and What to Do About It, 24 HEALTH AFF.
1436, 1437 (2005); Zhou Yang & Allyson G. Hall, The Financial Burden of Overweight
and Obesity Among Elderly Americans: The Dynanis of Weight, Longevity, and Health
Care Cost, 43 HEALTH SERVICES RES. 849, 854-60 (2008).
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higher health care expenditures of the overweight and obese in a
single year could be offset by shorter longevity if obesity is
negatively correlated with lifespan.44 Thus, estimating Medicare
costs associated with obesity using a cross-sectional analysis
could overestimate future Medicare cost. On the other hand,
however, average body weight in the elderly changes in
accordance with the natural biological aging process that
involves development of chronic disease, deterioration of
functional ability, and the associated medical treatment.45
Previous research has found that older survivors tend to
naturally decline in BMI as they age.46 Therefore, to only
consider Medicare expenditures associated with cross-sectional
body weight could also underestimate future Medicare
expenditures.
Second, similar issues exist when investigating lifetime
Medicare expenditures by gender, race, and height. For
example, women tend to have lower expenditures per year and
a lower probability of acute health events, but higher lifetime
expenditures than men due to longer longevity and a higher
prevalence of chronic disease.47 Similarly, blacks tend to have
higher health care costs per year, but lower lifetime expenditures
than whites due to shorter longevity.48 Not to consider these
issues could either over- or under-estimate future Medicare costs
attributed to demographic or biological changes in the
beneficiary population.
On net, beneficiaries who are overweight and obese at age
sixty-five will have worse health outcomes, shorter longevity,
44. Katherine M. Flegal et al., Excess Deaths Associated with Underweight,
Overweight, and Obesity, 293 JAMA 1861, 1865 (2005).
45. Yang & Hall, supra note 43, at 851.
46. Anne B. Newman et al., Weight Change in Old Age and its Association with
Mortality, 49 J. AM. GERIATRICS SOC'Y 1309, 1309 (2001).
47. See Anne Case & Christina Paxson, Sex Differences in Morbidity and Mortality,
42 DEMOGRAPHY 189, 201-05 (2005).
48. Katherine Baicker et al., Who You Are and Where You Live: How Race and
Geography Affect the Treatment of Medicare Beneficiaries, 23 HEALTH AFF. VAR-33,
VAR-42 (Supp. 2004); Zhou Yang & Adam Atherly, Racial and Gender Disparities in
Body Size, Survival, and Medicare Expenditures: Looking Beyond Cross-Sectional BMI
Economics and Human Biology, 19 (2010) (working paper, on file with author).
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and a higher disability rate than those with normal body
weight. 9 Total lifetime Medicare spending will increase by
between $2000 and $10,000 per person, depending on gender
and race.s0 Future Medicare beneficiaries (those currently in
their fifties) will have an even higher obesity rate than the
current population. 1
ASSESSING PREVENTATIVE MEASURES
Medicare faces severe future spending issues because, in the
near future, there will be more beneficiaries - both in absolute
terms and relative to workers - who receive health care which is
relatively more expensive. Further, these future beneficiaries
will also be, as a group, more obese with more chronic illness
necessitating the consumption of more care per person.
Medicare is thus facing a future where it needs to provide
coverage for more beneficiaries, for more years, who are sicker
and are consuming more care, at a higher price each year.
CAN PREVENTION HELP?
When thinking of Medicare spending, there are a number of
different ways to slice up spending. Many programs focus on
high-cost individuals. There are two different ways to approach
the high-cost individuals. First, the costs for high-cost, sick
beneficiaries can be managed and attempts made to minimize
costs. This is the idea behind programs like disease
management programs - take individuals who are already high
cost and attempt to manage their illness so to both control costs
and maintain health. Second, attempts can be made to prevent
these high-cost illnesses from occurring in the first place. Both
of these are sometimes called "prevention".
The term "prevention" is defined differently by different
49. Yang & Atherly, supra note 48, at 19.
50. See Id.
51. Id. at 18.
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researchers. One useful categorization provided by Goetzel,
groups prevention measures into three categories:52
* Primary prevention: Health promotion measures
targeted at healthy individuals which are designed
to keep individuals from becoming unhealthy.
* Secondary prevention: Health promotion measures
targeted at individuals with the preconditions for
developing costly illnesses designed to prevent
those conditions from progressing.
* Tertiary prevention: Health promotion measures
targeted at individuals who are already sick
designed to manage their illness efficiently to
minimize cost and maximize health.53
The cost effect of prevention thus depends on whether the
program is designed for primary, secondary or tertiary
prevention.
THE POTENTIAL FOR SAVINGS FROM PRIMARY PREVENTION
At age sixty-five, approximately 55% of the Medicare
population could be characterized as "low risk", based on their
risk categorization. 54 By age eighty-eight, only 25% of the
Medicare population could still be characterized as low risk, as
the high-risk (high-cost) beneficiaries climb from 31% of the
population at age sixty-five to over 50% by age eighty-four.55
From age seventy to seventy-four, more than one in three low-
risk beneficiaries transition from low risk to high risk; similarly,
during the same age range, more than one in four medium-risk
52. Ron Z. Goetzel, Do Prevention or Treatment Services Save Money? The Wrong
Debate, 28 HEALTH AFF. 37,38-39 (2009).
53. Id.
54. HEALTHWAYS CTR. FOR HEALTH RESEARCH, POTENTIAL MEDICARE SAVINGS
THROUGH PREVENTION AND HEALTH RISK REDUCTION 5 (2009), available at
http://www.healthways.com/success/library.aspx?
id=559. Low, medium and high risk are based on the CMS Hierarchical Condition
Category model, which bases risk on the number of chronic diseases. Id. at 3.
55. Id. at 5.
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beneficiaries transition from medium to high risk.56
In an actuarial model, the Center for Health Research finds
that reducing the rate of transition from low risk to high risk by
ten percent would both extend life expectancy and reduce
spending by approximately $4361 per beneficiary.57 Increasing
the baseline proportion of beneficiaries who are low risk will
also extend life expectancy and reduce total spending per
beneficiary by approximately $30,492 per beneficiary."
Combining the two programs (increasing the proportion of
beneficiaries who are low risk to sixty-five percent of sixty-five
year olds and eliminating ten percent of transitions) would save
the Medicare program approximately $65 billion per year.5 9
This demonstrates that there are extensive potential savings
from primary prevention. Another way of showing this
potential savings is shown by Joyce and co-authors, who find
that eliminating chronic illnesses in the sixty-five year old
population would reduce lifetime spending by 16%.60 There are
two limitations, however. First, these analyses exclude the cost
of whatever intervention would be used to prevent the
transitions or eliminate chronic illnesses. Second, no such
intervention exists.
THE POTENTIAL FOR SAVINGS FROM SECONDARY PREVENTION
Much of the increase in health care spending over the past
several decades is associated with secondary prevention.
Thorpe and Howard show that the proportion of beneficiaries
who had the recommended weight and were treated for five or
more chronic conditions increased from 12% to 16% between
1987 and 2002.61 Overall, the percentage of total Medicare
56. Id.
57. Id. at 6.
58. Id.
59. Id.
60. Geoffrey F. Joyce et al., The Lifetime Burden of Chronic Disease Among the
Elderly, 24 HFALTH AFF. W5-R18, W5-R27 (Supp. 2,2005).
61. Kenneth E. Thorpe & David H. Howard, The Rise in Spending Among
Medicare Beneficiaries: The Role of Chronic Disease Prczalence and Changes in Treatit'nt
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spending accounted for by these beneficiaries increased from 20
to 24%.62 This is despite the fact that many of these beneficiaries
were healthy; in 1987, 33% of these beneficiaries reported good
or excellent health.,,' By 2002, this had increased to 60%.64
This may be because of secondary prevention, with
physicians more aggressively diagnosing and treating healthier
beneficiaries. 65  During that time span, a number of new
technologies were introduced to treat or detect chronic
conditions at earlier, less severe stages. 66 For example, the DXA
scan for osteoporosis allows earlier detection of the chronic
illness.67
Secondary prevention has been aggressively introduced
over the past several decades, and it appears that it has led to a
substantial increase in both health and health care costs.
THE POTENTIAL FOR SAVINGS FROM TERTIARY PREVENTION
Tertiary prevention is sometimes considered the low-
hanging fruit in terms of cost savings. Because most health care
spending is concentrated in a relatively small number of sick
beneficiaries, it is reasonable to think that relatively small
proportionate reductions in spending may yield substantial
savings. Despite this, Medicare has implemented relatively few
interventions designed to reduce either the prevalence of chronic
illnesses or the cost of such illnesses once they occur.
One intervention that was implemented by the Center for
Medicare & Medicaid Services (CMS) was the Medicare Health
Support (MHS) Pilot Program.68 MHS allowed the development
of voluntary chronic care improvement programs designed to
improve the quality of care provided to individuals with one of
Intensity, 25 HEALTH AFF. W378, W384 (Supp. 2006).
62. Id.
63. Id. at W383.
64. Id.
65. MEDICARE PAYMENT ADVISORY COMM'N, supra note 33, at 10.
66. Id.
67. Id. at 8.
68. Id. at 15.
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three chronic illnesses. 69 The policy purpose of the program was
to test intervention strategies that may be adapted nationally to
improve clinical quality, increase beneficiary and provider
satisfaction, and achieve targeted savings for chronically ill
Medicare fee-for-service (FFS) beneficiaries. 70
The programs were highly ambitious in nature; the goal
was to improve individuals' quality of life through better quality
of care while simultaneously reducing total Medicare
expenditures by improved adherence to recognized or evidence-
based standards of care, thus reducing unnecessary use of high
cost hospital services - both inpatient and emergency room -
and avoidable complications, which in turn also lead to the
avoidable use of services.71 The program targeted high-cost
beneficiaries in one of three target groups: Chronic Obstructive
Pulmonary Disease (COPD), complex diabetes, and congestive
heart failure (CHF).72 These high-risk / high-cost beneficiaries
provide theoretical opportunities for cost savings and quality
improvements.
As part of the enabling legislation, Congress mandated
CMS conduct an independent evaluation of the MHS project and
submit reports to Congress on the program.73 CMS selected RTI
International to conduct the evaluation. 74 RTI has submitted two
reports to Congress on the MHS program to date, the first in
June, 2007, and the second in October, 2008.75 Neither report
69. NANCY MCCALL ET AL., RTI INT'L, EVALUATION OF PHASE I OF MEDICARE
HEALTH SUPPORT (FORMERLY VOLUNTARY CHRONIC CARE I\PROVE IMENT) PILOT
PROGRAM UNDER TRADITIONAL FEE-FOR-SERVICE MEDICARE, REPORT TO CONGRESS 7
(2007), available at https://www.cms.gov/reports/ downloads/McCall .pdf.
70. NANCY MCCALL FT AL., RTI INT'L, EVALUATION OF PHASE I OF MEDICARE
HEALTH SUPPORT PILOT PROGRAM UNDER TRADITIONAL FFE-FOR-SERVICE
MEDICARE: 18-MONTII INTERIM ANALYSIS, REPORT TO CONGRESS, 11 (2008), available
at https://www.cms.gov/reports/downloads/MHSSecondReport-to
CongressOctober_2008.pdf.
71. Id. at 5.
72. McCall, supra note 69, at 7.
73. Id. at 6.
74. Id. at ii.
75. McCall, supra note 70, at 1.
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found any savings associated with the program.76
This is consistent with studies in other populations.77 In a
systematic review of the literature, analysts at the RAND
Corporation found that evidence about cost savings for disease
management programs is inconclusive.78 Disease management
programs focused on congestive heart failure reduced inpatient
admissions, but did not always reduce spending.79 Programs for
depression, coronary artery disease, and diabetes all had health
benefits but were not able to consistently demonstrate cost
savings.s0 A Congressional Budget Office (CBO) report from
2004 reached similar conclusions.8'
Overall, similar to secondary prevention, tertiary
prevention provides substantial benefits in terms of health for
program recipients. However, there is not a clear cost reduction
associated with the programs. With the right design and the
right population, some programs do demonstrate savings.
However, this result is not uniform across different conditions,
programs, and populations.
CAN PREVENTION WORK?
Interventions which both increase health and reduce costs
are easily justified and widely supported. Unfortunately,
interventions of this type are relatively rare. There have been
many hundreds of cost-effectiveness studies over the past half
century of interventions ranging from pharmaceuticals to case
management to self-management, and most interventions tend
to both improve health and increase costs. 82 In a review of
76. McCall, supra note 69, at 46; McCall, supra note 70, at 79.
77. See Soeren Mattke et al., Evidence for the Effect of Disease Management: Is $1
Billion a Year a Good Investment?, 13 AM. J. OF MANAGED CARE 670, 674 (2007).
78. Id. at 674-75.
79. Id. at 675.
80. Id.
81. CONGRESSIONAL BUDGET OFFICE, AN ANALYSIS OF THE LITERATURE ON
DISEASE MANAGEMENT PROGRAMS 8 (2004), available at http://www.cbo.gov
/ftpdocs/59xx/doc5909/10-13-DiseaseMngmnt.pdf.
82. See Joshua Cohen et al., Does Preventive Care Save Money? Health Economics
and the Presidential Candidates, 358 NEW ENG. J. MED. 661, 661-63 (2008).
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studies of prevention measures reporting a cost-effectiveness
ratio, Cohen et al., report that less than one in five studies find
that prevention reduces costs.8 3 Instead, the vast majority find
that prevention increases costs and provides some benefit. 84
Many of the standard preventive measures fail to reduce
spending. Russell summarizes much of the standard findings
from the literature and provides several examples:85
* Hypertension treatment is effective in reducing the
risk of heart disease and stroke, but the cost of
treatment is greater than the savings through disease
avoidance because of the duration of the treatment
and the number of people who would not have had
the high cost events. 6
* Diabetes prevention programs which prevent
diabetes through diet and exercise can reduce the
rate of diabetes incidence by half with a cost of
nearly $200,000 per life year gained.87
* Similarly, screening for cervical cancer, colorectal
cancer, and breast cancer all save lives but increase
costs. 8
The reason that prevention rarely reduces costs is because
the cost savings associated with early treatment or detection (or
disease avoidance) are typically far less than the costs associated
with the direct cost of the preventive service, costs associated
with adverse reactions to the preventive services, costs
associated with follow-up treatment and testing for those with a
positive screen, and the cost of unrelated illnesses that occur late
in life. 9
83. Id. at 662.
84. Id. at 662-63 (a small number showing an increase costs and reduction in
health).
85. Louise B. Russell, Preventing Chronic Discase: An Important Ineustmncnt, But
Don't Count on Cost Savings, 28 HEALTH AFF. 42,45 (2009).
86. Id. at 43.
87. Id. at 43-44.
88. Id. at 44.
89. Kip Sullivan, Congrcssional Budget Office: Prevention + Disease Management Do
Not Cut Costs, Dec. 2008, http://mnhealthplan.org/readings.html.
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This is not to say that prevention is a bad idea. As a result
of the efforts to reduce chronic illness, there has been a marked
decrease in the number of Medicare beneficiaries who are
disabled.90 This can help in health care spending because the
disabled tend to be more costly than those without disabilities.9'
However, health care costs among nondisabled Medicare
beneficiaries have been increasing much more quickly than
health care costs among the disabled.92 This may well reflect the
costliness of efforts to prevent beneficiaries with potentially
disabling conditions from becoming actually disabled. While
this may be a justifiable use of societal resources, it does increase
Medicare costs.
For example, there is currently considerable interest in the
Diabetes Prevention Program (DPP).93 DPP has shown (in a
major multicenter clinical research study) that modest weight
loss through dietary changes and increased physical activity can
prevent or delay the onset of type two diabetes. 94 In the trial,
DPP enrolled overweight Medicare beneficiaries with pre-
diabetes (blood glucose levels higher than normal but not high
enough for a diagnosis of diabetes).95 The participants that lost a
modest amount of weight through dietary changes and
increased physical activity sharply reduced their chances of
developing diabetes. 96 Further studies found that the program
would cost the health care system $8181 to gain one quality-
adjusted life-year among participants in the screening
program.97 Again, the DPP leads to both higher costs and better
health.
90. See MEDICARE PAYMENT ADVISORY COMM'N, supra note 33, at xi.
91. Id. at 3.
92. Id. at 10.
93. See Diabetes Prevention Program Research Group, Reduction in the Incidence
of Type 2 Diabetes with Lifestyle Intervention or Metformin, 346 NEW ENG. J. MED. 393,
401 (2002).
94. Id. at 394, 398.
95. See id. at 394.
96. Id. at 394, 398.
97. Thomas Hoerger et al., Cost-Effectiveness of Screening for Pre-Diabetes Among
Overweight and Obese U.S. Adults, 30 DIABETES CARE 2874, 2876 (2007).
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Yet, the tantalizing potential remains for reforms which
improve health and reduce costs. It is well known that
considerable health care resources are spent on unnecessary
care. One of the most famous examples is avoidable
hospitalizations, which are hospitalizations which the medical
community believes should not occur if the patient were given
proper care.98 For example, if an individual has asthma, and the
asthma is properly managed, the individual will not need
hospital care due to his or her asthma. Therefore, it is argued, if
an individual is hospitalized for asthma, this represents a failure
in the management of asthma. The hospitalization is therefore
"avoidable" with proper management. These hospitalizations
are also sometimes referred to as being "preventable
hospitalizations." These avoidable hospitalizations typically
occur in persons with chronic illnesses, such as congestive heart
failure, chronic obstructive pulmonary disease, hypertension,
diabetes, and asthma.99 Measuring and preventing avoidable
hospitalizations is possible and has been done successfully.'
Another example is the Community Care of North Carolina
program.101 This program used an enhanced medical home
model of care in its Medicaid program.10 2 It links individuals
with a provider to create a medical home and uses care
coordination, disease and care management, and quality
improvement initiatives to improve care and reduce costs. 03
The state of North Carolina has had two external evaluations of
the program, both of which suggested improved care and
reduced costs.10 4 Total costs for 2006 were estimated at $150-
98. Steven D. Culler et al., Factors Related to Potentially Preventable
Hospitalizations Among the Elderly, 36 MED. CARE 804, 804-05 (1998).
99. Id. at 805.
100. Andrew J. Epstein, The Role of Public Clinics in Preventable Hospitalizations
Among Vulnerable Populations, 36 HEALTH SERVICES RES. 405, 415 (2001).
101. KAISER COMMISSION ON MEDICAID AND THE UNINSURED, KAISER FAMILY
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$170 million.105 For individuals with asthma and diabetes, the
state saved $5.4 million, with reductions in inpatient hospital
admissions and emergency room visits, and higher scores on
performance measures, such as primary care visits, blood
pressure readings, foot exams, and lipid and AIC tests.1 0
CONCLUSION
Medicare is a highly fragmented system. The typical Medicare
beneficiary:
* has multiple chronic illnesses;
* sees two primary care physicians and five specialists
working in four different physician practices per
year; and
* receives fifty-six percent of recommended care per
year.107
This suggests that there is substantial waste in the system
and also substantial room for improved care. This is the reason
for the interest in the Community Care of North Carolina
program - it suggests that defragmenting the system could both
reduce costs and improve care. Garber et al. point out that:
* the RAND health insurance experiment found that
total spending per capita could be reduced by thirty
percent without a negative health effect;
* health quality studies suggest that thirty percent of
delivered care is unnecessary; and
* there is a thirty percent variation in the cost of dying
in the United States in the Medicare population.10s
The repeated thirty percent is likely a coincidence, but it
strongly suggests that the potential for substantial cost savings
coupled with care improvements remains. However, the
105. Id. at 6.
106. Id. at 5.
107. Kenneth E. Thorpe et al., Chronic Conditions Account for Rise in Medicare
Spending from 1987 to 2006, 29 HEALTH AFF. 718, 723 (2010).
108. Alan Garber et al., The Promise of Health Care Cost Containment, 26 HEALTH
AFF. 1545, 1546-47 (2007).
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challenge remains in the replication and generalization of
successful interventions that can realize this potential.
